Additionally, increased EP3 expression is associated with higher tumor status, higher the International Federation of Gynecology and Obstetrics (FIGO)-classification, as well as with poorer survival (Heidegger et al. 2017). The gene discussed is PTGER3; the disease is neoplasm.